Skip to content

Clinical trials

Phase 2 RNA Virus Infections trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: RNA Virus Infections Phase: Phase 2 Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20132
20142
20152
20162
20172
20201
20211
20222
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Medicago6
Gilead Sciences2
Altesa Biosciences, Inc.1
Assistance Publique - Hôpitaux de Paris1
BioNTech SE1
Biomedical Advanced Research and Development Authority1
London School of Hygiene and Tropical Medicine1
Merck Sharp & Dohme LLC1
Myrexis Inc.1
National Institute of Allergy and Infectious Diseases (NIAID)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
RNA Virus Infections18
Virus Diseases17
Respiratory Tract Infections12
Infections11
Respiratory Tract Diseases11
Influenza, Human7
Orthomyxoviridae Infections7
Flaviviridae Infections3
Hepatitis C3
Liver Diseases3

Trials

Showing 76 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.